This page serves as the disclosure of financial interests and conflicts of interest for Scott D. Weingart, MD FCCM.
Dr. Weingart will not fill out any specific forms as these actions serve as a waste of time and effort. Please print this page and attach to your own form.
Financial Relationships with Commercial Interests
- I have had no financial relationships, related to any CME activity, in the last 24 month
s with any entity whose primar y business is producing, marke ting, selling, re‐selling, or distributing healthcare produc ts used by or on patients, i.e. an ACCME ineligible company/ commercial interest (addresses financial conflict of interest)
Standards for Educational Activities
- All scientific research I refer to, report and use in presentations to support patient care recommendations conform to the generally accepted standards of experimental design, data collection and analysis
- If presenting research funded by a commercial company, the information presented will be based on generally accepted scientific principles and methods and will not promote the commercial interest(s) of the funding company
- Educational content will be well-balanced, evidence-based (where possible) and unbiased. Source and type of evidence will be made clear to the participants (addresses content validation)
- All the recommendations involving clinical medicine in my presentations are based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. (addresses content validation). Limitations on information, including but not limited to data that represents ongoing research; interim analysis; preliminary data; unsupported opinion; or approaches to care that, while supported by some research studies, do not represent the only opinion or approach to care supported by research
- The content or format of my presentations and all the related materials promote improvements or quality in healthcare and not a specific proprietary business interest or commercial interest (addresses safe guards against commercial bias)
- My educational materials, slides, abstracts, handouts, etc., do not contain any advertising, trade names or product-group messages. No single product or service will be over-represented when other equal but competing products or services are available for inclusion (this addresses educational material)
- Whenever it does not lead to ambiguity, I use generic names of medications in all remarks. If trade names are mentioned, I will use those from several companies rather than only those of a single supporting company (addresses safeguards against commercial bias)
- I disclose to the audience all unlabeled or investigational uses of products or services in the remarks
- I comply with patient confidentiality requirements as outlined in the Health Insurance Portability and Accountability Act and will use only de-identified patient information (when applicable)
- I do not accept any direct remuneration, gifts or in-kind offerings from commercial supporter(s), nor to accept direct input from commercial supporter(s) regarding presentation content. No other remuneration is received beyond agreed arrangements.
Signed
Scott D. Weingart, MD FCCM
Metasin LLC / emcrit.org
The above is valid as of
March 26, 2025
You must be logged in to post a comment.